Search Results

A New Method to Measure Cardiac Inositol Levels in Intact Animals

• Authors : Paterna, S.; D'Amico, C.; Pasquale, P. Di

• Source: Journal of Pharmacological and Toxicological Methods; 1996, Vol. 35 Issue: 2 p107-110, 4p

Record details

EE483 Empagliflozin for Heart Failure Patients Irrespective of Ejection Fraction in Spain: A Cost-Effectiveness Study.

• Authors : Croci, F¹ (AUTHOR); Kolovos, S² (AUTHOR); Bellanca, L³ (AUTHOR)

Subjects: *HEART failure patients; *VENTRICULAR ejection fraction; *EMPAGLIFLOZIN

• Source: Value in Health. 2022 Suppl, Vol. 25 Issue 12, pS150-S150. 1p.

Record details

POSA126 An Economic Analysis of Empagliflozin Versus Sacubitril/Valsartan in Patients with Heart Failure with Reduced Ejection Fraction (HFREF) in the United Kingdom (UK).

• Authors : Reifsnider, O¹ (AUTHOR); Tafazzoli, A¹ (AUTHOR); Bellanca, L² (AUTHOR)

Subjects: *HEART failure patients; *VENTRICULAR ejection fraction; *ENTRESTOUNITED Kingdom

• Source: Value in Health. 2022 Supplement, Vol. 25 Issue 1, pS58-S58. 1p.

Record details

Mixing phenomena in circular and rectangular cross-sectional T-mixers: Experimental and numerical assessment.

• Authors : Battaglia, G.¹ (AUTHOR) ; Romano, S.¹ (AUTHOR); Raponi, A.^1,2 (AUTHOR)

Subjects: *IMAGE analysis; *COLORING matter in food; *FLUID flow

• Source: Chemical Engineering Research & Design: Transactions of the Institution of Chemical Engineers Part A. Jan2024, Vol. 201, p228-241. 14p.

Record details

PRM123 - Assessing The Joint Probability Of Cost-Effectiveness And Affordability In Decision Making.

• Authors : Yi, Y¹; Lucherini, S¹; Bellanca, L¹

• Source: Value in Health. Oct2017, Vol. 20 Issue 9, pA753-A753. 1p.

Record details

POSB22 Indirect Treatment Comparisons of Empagliflozin Versus Sacubitril/Valsartan for the Treatment of Patients with Heart Failure with Reduced Ejection Fraction (HFREF).

• Authors : Smith, S¹ (AUTHOR); Pilkington, H² (AUTHOR); Roskell, N³ (AUTHOR)

Subjects: *HEART failure patients; *VENTRICULAR ejection fraction; *ENTRESTO

• Source: Value in Health. 2022 Supplement, Vol. 25 Issue 1, pS29-S29. 1p.

Record details

A European multinational cost-effectiveness analysis of empagliflozin in heart failure with reduced ejection fraction.

• Authors : Tafazzoli A; Evidera, 7101 Wisconsin Avenue, Suite 1400, Bethesda, MD, 20814, USA.; Reifsnider OS

Subjects: Heart Failure*; Humans ; Cost-Effectiveness Analysis

• Source: The European journal of health economics : HEPAC : health economics in prevention and care [Eur J Health Econ] 2023 Dec; Vol. 24 (9), pp. 1441-1454. Date of Electronic Publication: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 101134867 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Multinational cost-effectiveness analysis of empagliflozin for heart failure patients with ejection fraction >40.

• Authors : Kolovos S; IQVIA, Athens, Greece.; Bellanca L

Subjects: Cost-Effectiveness Analysis* ; Heart Failure*; Humans

• Source: ESC heart failure [ESC Heart Fail] 2023 Dec; Vol. 10 (6), pp. 3385-3397. Date of Electronic Publication: 2023 Sep 05.Publisher: John Wiley & Sons Ltd on behalf of the European Society of Cardiology Country of Publication: England NLM ID: 101669191 Publication Model:

Record details

Cost-effectiveness of empagliflozin in heart failure patients irrespective of ejection fraction in England.

• Authors : Kolovos S; IQVIA, Athens, Greece.; Bellanca L

Subjects: Ventricular Function, Left* ; Heart Failure*/Heart Failure*/Heart Failure*/diagnosis ; Heart Failure*/Heart Failure*/Heart Failure*/drug therapy

• Source: Journal of cardiovascular medicine (Hagerstown, Md.) [J Cardiovasc Med (Hagerstown)] 2023 Oct 01; Vol. 24 (10), pp. 758-764. Date of Electronic Publication: 2023 Jul 25.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101259752 Publication Model: Print-Electronic Cited Medium:

Record details

Incidence and prevalence of heart failure in England: a descriptive analysis of linked primary and secondary care data - the PULSE study.

• Authors : Bellanca L; Boehringer Ingelheim Ltd, Bracknell, UK.; Linden S

Subjects: Heart Failure*/Heart Failure*/Heart Failure*/diagnosis ; Heart Failure*/Heart Failure*/Heart Failure*/epidemiology; Humans

• Source: BMC cardiovascular disorders [BMC Cardiovasc Disord] 2023 Jul 26; Vol. 23 (1), pp. 374. Date of Electronic Publication: 2023 Jul 26.Publisher: BioMed Central Country of Publication: England NLM ID: 100968539 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2261

Record details